Who’s on the couch here? The psychiatrist or the poet? The poem or the practice of psychiatry? As a poet and a psychiatrist/therapist, I exist in both practices, and the worlds of each enrich the other. Each speaks with abandon, and each interrogates the other, and there are many ways in which each discipline supports […]

You’re reading the web edition of AACR in 30 Seconds, STAT’s guide to the American Association for Cancer Research annual meeting. Sign up for email here.  Welcome to STAT’s annual newsletter covering the meeting of the American Association for Cancer Research. We’re glad you’re here. AACR is always a big meeting, usually attended by more […]

Vasan Ramachandran is baffled. A cardiologist and veteran of the famed Framingham Heart Study, he is struggling to understand why a similar study he brought to life in 10 rural counties across four Southern states is facing elimination. The RURAL Cohort Study, set in motion six years ago, was working toward its recruitment goal of […]

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. On Monday, the groundbreaking Women’s Health Initiative announced that the federal contracts funding the study’s 40 regional centers would end with the fiscal year. But on Thursday a federal official said the Department of Health and Human Services was reversing […]

The debate over the future of Medicaid continues to rage among Republicans. A House budget proposal released in February would slash up to $880 billion in spending over the next decade from the public health insurance program that 80 million low-income Americans rely on — including children, seniors, and people with disabilities. Last week, moderate […]

A landmark new treatment for schizophrenia didn’t provide additional benefits to patients when given on top of standard-of-care therapy, Bristol Myers Squibb announced Tuesday. The drug, Cobenfy, was approved last year based on data from three randomized studies comparing the drug to placebo. It was the first new mechanism-of-action approved for schizophrenia in decades. Doctors […]

Food manufacturers will phase out eight synthetic dyes from all U.S. products by the end of 2026, the federal government announced today in a move that reflects the growing reach of the Make America Healthy Again movement. Decrying the “toxic soup of synthetic chemicals” in Americans’ food supply, Food and Drug Administration head Marty Makary […]